Malignancies: pre and post transplantation strategies.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Transplantation reviews

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.trre.2013.12.002PMID 24439783
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characteristics of Early and Late PTLD Development in Pediatric Solid Organ Transplant Recipients

  2013cited by this paper
• Global estimates of cancer prevalence for 27 sites in the adult population in 2008

  2013cited by this paper
• Recommendations on screening for cervical cancer

  2013cited by this paper
• Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative Disorder

  2013cited by this paper
• Re: Independent of nephrectomy, weaning immunosuppression leads to late sensitization after kidney transplant failure.

  2013cited by this paper
• Overall and Cause-Specific Mortality in Transplant Recipients with a Pretransplantation Cancer History

  2013cited by this paper
• Renal tumors in solid organ recipients: clinical and pathologic features.

  2013cited by this paper
• Comparison of De Novo Cancer Incidence in Australian Liver, Heart and Lung Transplant Recipients

  2013cited by this paper
• Screening for colorectal cancer and advanced colorectal neoplasia in kidney transplant recipients: cross sectional prevalence and diagnostic accuracy study of faecal immunochemical testing for haemoglobin and colonoscopy

  2012cited by this paper
• Randomized Controlled Trial of Sirolimus for Renal Transplant Recipients at High Risk for Nonmelanoma Skin Cancer

  2012cited by this paper
• Screening for head and neck cancer in liver transplant candidates: A review of 11 years of experience at the University of Pittsburgh

  2012cited by this paper
• Malignancies After Kidney Transplantation: Hong Kong Renal Registry

  2012cited by this paper
• Canadian Task Force on Preventive Health Care

  2012cited by this paper
• Posttransplant Malignancies in Solid Organ Adult Recipients: An Analysis of the U.S. National Transplant Database

  2012cited by this paper
• Sirolimus and secondary skin-cancer prevention in kidney transplantation.

  2012cited by this paper
• Malignancies after renal transplantation in Taiwan: a nationwide population-based study.

  2012cited by this paper
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

  2012cited by this paper
• Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.

  2012cited by this paper
• Associations Between EBV Serostatus and Organ Transplant Type in PTLD Risk: An Analysis of the SRTR National Registry Data in the United States

  2012cited by this paper
• Clinical Practice Guidelines on Wait-Listing for Kidney Transplantation: Consistent and Equitable?

  2012cited by this paper
• Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.

  2012cited by this paper
• Association of Immunosuppressive Maintenance Regimens With Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients

  2012cited by this paper
• Alemtuzumab Induction Therapy in Kidney Transplantation: A Systematic Review and Meta-Analysis

  2012cited by this paper
• Imaging of cancer predisposition syndromes in children.

  2011cited by this paper
• Monoclonal Gammopathy of Undetermined Significance Does Not Affect Outcomes in Patients Undergoing Solid Organ Transplants

  2011cited by this paper
• Recommendations on screening for breast cancer in average-risk women aged 40–74 years

  2011cited by this paper
• Lower Malignancy Rates in Renal Allograft Recipients Converted to Sirolimus-Based, Calcineurin Inhibitor-Free Immunotherapy: 24-Month Results From the CONVERT Trial

  2011cited by this paper
• Reduced lung-cancer mortality with low-dose computed tomographic screening.

  2011cited by this paper
• Screening for renal cancer in recipients of kidney transplants.

  2011cited by this paper
• Spectrum of cancer risk among US solid organ transplant recipients.

  2011cited by this paper
• Donor‐Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk

  2011cited by this paper
• Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.

  2011cited by this paper
• Risk factors for early‐onset and late‐onset post‐transplant lymphoproliferative disorder in kidney recipients in the United States

  2011cited by this paper
• Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies

  2011cited by this paper
• Screening colonoscopy and detection of neoplasia in asymptomatic, average‐risk, solid organ transplant recipients: case–control study

  2010cited by this paper
• Long-term cancer risk of immunosuppressive regimens after kidney transplantation.

  2010cited by this paper
• Reduction in Cardiovascular Death After Kidney Transplantation

  2010cited by this paper
• First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.

  2010cited by this paper
• A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

  2010cited by this paper
• Comparison of the Incidence of Malignancy in Recipients of Different Types of Organ: A UK Registry Audit

  2010influential reference
• Interleukin 2 receptor antagonists for kidney transplant recipients.

  2010cited by this paper
• Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study

  2010cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

  2010cited by this paper
• Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder

  2010cited by this paper
• Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients

  2010cited by this paper
• The Health and Economic Impact of Cervical Cancer Screening and Human Papillomavirus Vaccination in Kidney Transplant Recipients

  2009cited by this paper
• Epidemiologic critique of literature on post‐transplant neoplasms in solid organ transplantation

  2009cited by this paper
• The pattern of excess cancer in dialysis and transplantation.

  2009cited by this paper
• Association of CKD and cancer risk in older people.

  2009cited by this paper
• Extensive Surveillance Promotes Early Diagnosis and Improved Survival of De Novo Malignancies in Liver Transplant Recipients

  2009cited by this paper
• Cancer Mortality in Kidney Transplantation

  2009cited by this paper
• Mycophenolate Mofetil Decreases Acute Rejection and may Improve Graft Survival in Renal Transplant Recipients When Compared with Azathioprine: A Systematic Review

  2009cited by this paper
• Immunosuppressive Drugs in Kidney Transplantation

  2009cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009cited by this paper
• Managing Cancer Risk and Decision Making After Kidney Transplantation

  2008cited by this paper
• Cancer screening in renal transplant recipients: what is the evidence?

  2008cited by this paper
• Transplantation Risks and the Real World: What Does ‘High Risk’ Really Mean?

  2008cited by this paper
• mTOR pathway and mTOR inhibitors as agents for cancer therapy.

  2008cited by this paper
• Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

  2008cited by this paper
• Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors.

  2008cited by this paper
• Informing candidates for solid-organ transplantation about donor risk factors.

  2008cited by this paper
• Cost-Effectiveness of Colorectal Cancer Screening in Renal Transplant Recipients

  2008cited by this paper
• Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis.

  2007influential reference
• Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update.

  2007cited by this paper
• Identifying High Risk Groups and Quantifying Absolute Risk of Cancer After Kidney Transplantation: A Cohort Study of 15 183 Recipients

  2007cited by this paper
• Renal cell carcinoma in transplant recipients with acquired cystic kidney disease.

  2007cited by this paper
• Cancer Incidence Among Canadian Kidney Transplant Recipients

  2007cited by this paper
• Review of Epstein–Barr virus and post‐transplant lymphoproliferative disorder post‐solid organ transplantation (Review Article)

  2006cited by this paper
• Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials

  2006cited by this paper
• Post‐transplant de novo malignancies in renal transplant recipients: the past and present

  2006cited by this paper
• Cancer incidence before and after kidney transplantation.

  2006cited by this paper
• The United Network for Organ Sharing position on using donors with primary central nervous system malignancies.

  2005cited by this paper
• Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies

  2005cited by this paper
• Canadian Society of Transplantation consensus guidelines on eligibility for kidney transplantation

  2005cited by this paper
• Management of hepatocellular carcinoma

  2005cited by this paper
• AASLD PRACTICE GUIDELINE AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation

  2005cited by this paper
• Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation

  2005cited by this paper
• HEPATOLOGY by Hepatologists

  2005cited by this paper
• Cancer after Kidney Transplantation in the United States

  2004cited by this paper
• Immunosuppression and the Risk of Post‐Transplant Malignancy Among Cadaveric First Kidney Transplant Recipients

  2004cited by this paper
• Lymphomas After Solid Organ Transplantation: A Collaborative Transplant Study Report

  2004cited by this paper
• Use of donors with central nervous system malignancies: Proceed with caution

  2004cited by this paper
• Current Recommendations for Delaying Renal Transplantation after Localized Prostate Cancer Treatment: Are They Still Appropriate?

  2004cited by this paper
• Cancer risk following organ transplantation: a nationwide cohort study in Sweden

  2003cited by this paper
• Screening for Prostate, Breast and Colorectal Cancer in Renal Transplant Recipients

  2003cited by this paper
• European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment.

  2002cited by this paper
• Transplant tumor registry: donor related malignancies

  2002cited by this paper
• SECTION IV: Long-term management of the transplant recipient

  2002cited by this paper
• Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation

  2002cited by this paper
• Contribution of genetically engineered animals to the analyses of complement in the pathogenesis of nephritis.

  2002cited by this paper
• Non‐melanoma skin cancer risk in the Queensland renal transplant population

  2002cited by this paper
• The evaluation of renal transplantation candidates: clinical practice guidelines.

  2001cited by this paper
• GUIDELINES FOR THE REFERRAL AND MANAGEMENT OF PATIENTS ELIGIBLE FOR SOLID ORGAN TRANSPLANTATION

  2001cited by this paper
• Cancer incidence in a kidney‐transplanted population

  2000cited by this paper
• Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation.

  2000cited by this paper
• European Best Practice Guidelines for Renal Transplantation (part 1).

  2000cited by this paper
• Solute fluxes in different treatment modalities.

  2000cited by this paper
• Cancer in patients on dialysis for end-stage renal disease: an international collaborative study.

  1999cited by this paper
• De novo malignances in pediatric organ transplant recipients.

  1998cited by this paper
• Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation.

  1995cited by this paper

• Mammographic Calcifications in Lung Transplant Recipients: Prevalence and Evolution

  2025cites this paper
• Postrenal transplant malignancy: An update for clinicians

  2023cites this paper
• Evaluation of 18-FDG PET diagnostic capabilities for cancer screening in heart transplant patients, a retrospective study

  2023cites this paper
• Allogeneic hematopoietic cell transplantation in patients with a hematologic malignancy and a prior history of breast cancer

  2022cites this paper
• A Case of Esophageal Cancer Treated by Thoracoscopic Esophagectomy after Bilateral Cadaveric Lung Transplantation

  2022cites this paper
• Immunosenescence as a reason of individualizing immunosuppressive therapy in kidney transplantation

  2021cites this paper
• The effect of subsequent immunosuppressant use in organ-transplanted patients on prostate cancer incidence: a retrospective analysis using the Korean National Health Insurance Database

  2021cites this paper
• Chronic lymphocytic leukemia/small lymphocytic lymphoma complicated with skin Langerhans cell sarcoma: A case report

  2021cites this paper
• CNS Post-Transplant Lymphoproliferative Disorder in a Heart Recipient: A Case Report.

  2021cites this paper
• Evaluation of rejection, infection, and malignancy outcomes in elderly liver transplant recipients receiving a similar level of immunosuppression compared to a younger group.

  2021cites this paper
• Incidence of malignancy and related mortality after kidney transplantation: a nationwide, population-based cohort study in Korea

  2020cites this paper
• Tumorrisiken nach Organtransplantation

  2020cites this paper
• De-novo malignancies after kidney transplantation: A long-term observational study

  2020cites this paper
• Anesthesia of the conditioned limb does not abolish the remote ischemic conditioning stimulus on cutaneous microcirculation in humans

  2019cites this paper
• A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature

  2019cites this paper
• Immunosenescence and Immunosuppressive Drugs in the Elderly

  2019cites this paper
• Der differenzierte Einfluss der Seneszenz auf die Organtransplantation und Leberteilresektion

  2019cites this paper
• Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.

  2019cites this paper
• Tumorscreening bei Nierentransplantation

  2019cites this paper
• Tumorrisiken nach Organtransplantation

  2019cites this paper
• Solid Organ Cancer and Melanoma in Kidney Transplant Recipients: TumorTx Base Preliminary Results.

  2018cites this paper
• National survey of de novo malignancy after solid organ transplantation in Japan

  2018cites this paper
• Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report

  2018cites this paper
• Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines

  2017cites this paper
• Cytomegalovirus‐negative kidney transplant recipients are at an increased risk for malignancy after kidney transplantation

  2016cites this paper
• Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients

  2016cites this paper
• [Urologic malignancies in renal transplant candidates and recipients].

  2016cites this paper
• Urothelial carcinoma of donor origin in a kidney transplant patient

  2016cites this paper
• Risk of renal cancer in liver transplant recipients: A systematic review and meta-analysis.

  2016cites this paper
• Targeted Cancer Screening After Solid-Organ Transplantation.

  2016cites this paper
• De novo malignancy after lung transplantation in Japan

  2016cites this paper
• Aspects of Autophagy in Inflammatory Bowel Disease

  2016cites this paper
• Histopathology and prognosis of de novo bladder tumors following solid organ transplantation

  2015cites this paper
• Tumorrisiko nach Nierenlangzeittransplantation – Aspekte der Immunsuppression

  2015cites this paper
• Malignancy in Kidney Transplantation: A 25-Year Single-center Experience in Portugal.

  2015cites this paper
• Langerhans cell sarcoma: a systematic review.

  2015cites this paper
• Yield of screening colonoscopy in renal transplant candidates.

  2015cites this paper
• A Rationale for Age-Adapted Immunosuppression in Organ Transplantation

  2015cites this paper
• Contribution of TLR signaling to the pathogenesis of colitis-associated cancer in inflammatory bowel disease.

  2014cites this paper
• Con: The challenges of utilizing expanded-criteria donors for orthotopic heart transplantation.

  2014cites this paper